OnabotulinumtoxinA improves oral aperture in patients with scleroderma: A small clinical trial.

导出原文传递

翻译打印收藏纠错

第一作者： Cristian D,Gonzalez

第一单位： Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.

作者： Cristian D,Gonzalez ^[1] ; Jarod John,Pamatmat ^[2] ; Kevin M,Burningham ^[2] ; Michelle,Yang ^[1] ; Heather W,Goff ^[3]

作者单位： Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas. ^[1] University of Texas Southwestern Medical School, Dallas, Texas. ^[2] Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: heather.goff@utsouthwestern.edu. ^[3]

关键词 diffuse scleroderma limited mouth opening microstomia neuromodulator onabotulinumtoxinA reduced oral aperture scleroderma systemic sclerosis

DOI 10.1016/j.jaad.2023.04.069

PMID 37301288

发布时间 2023-10-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交